BOCA RATON, Fla., April 01, 2019 (GLOBE NEWSWIRE) -- Dawson James Securities Inc. in conjunction with Precision Therapeutics Inc. (NASDAQ: AIPT) announced the closing on March 28th of its public offering of 1,478,750 units at $.80 per unit. Each unit consisted of one share of common stock and a warrant to purchase 0.5 of one share of common stock. The exercise price of the warrants is $1.00 per share and expires in March 2024.
The Company received gross proceeds of approximately $1,183,000 million from this offering which will be used for working capital and general corporate purposes.
Dawson James Securities, Inc. acted as the exclusive placement agent for the offering.
About Precision Therapeutics Inc.
Precision Therapeutics operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for patients and clinicians as well as clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal.
About Dawson James Securities
Dawson James Securities specializes in capital raising for small and microcap public and private growth companies primarily in the Life Science/Health Care, Technology and Consumer sectors and is a full-service investment banking firm with research, institutional and retail sales, and execution trading and corporate services. Headquartered in Boca Raton, FL, Dawson James is privately held with offices in New York, Maryland and New Jersey. www.dawsonjames.com
